Clinical trial
ALTAIR - Alternative Antiretroviral Strategies: a Comparison of Three Initial…
NCT00335322 · Kirby Institute, Other · Completed
Key facts
| NCT number | NCT00335322 |
|---|---|
| Title | ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens |
| Official title | A Randomised, Open-label, 96-week Study Comparing the Safety and Efficacy of Three Different Combination Antiretroviral Regimens as Initial Therapy for HIV Infection. |
| Lead sponsor | Kirby Institute, Other |
| Collaborators | The University of New South Wales |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Human Immunodeficiency Virus (HIV) |
| Intervention type | Drug |
| Interventions | Truvada (fixed dose combination of tenofovir + emtricitabine) + Stocrin (efavirenz), Truvada (fixed dose combination of tenofovir + emtricitabine)+ ritonavir/atazanavir (r/ATV), Truvada (fixed dose combination of tenofovir + emtricitabine) + zidovudine (ZDV) + abacavir (ABC) |
| Enrollment | 329 |
| Start date | Feb 1, 2007 |
| Primary completion | Mar 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Jun 9, 2006 |
| Last update posted | Sep 26, 2019 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: